PCN13 REAL LIFE OUTCOMES IN 2ND LINE ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)- A PILOT STUDY IN FRANCE AND GERMANY ANALYSING ERLOTINIB VERSUS CHEMOTHERAPY
Abstract
Authors
A. Vergnenegre D.F. Heigener H.G. Bischoff C. Chouaid G. Taylor-Stokes A. Roughley S. Walzer